114 related articles for article (PubMed ID: 6130649)
21. Construction and use of cDNA clones for the mapping and identification of Epstein-Barr virus early P3HR-1 mRNAs.
Manet E; Chevallier A; Zhang CX; Ooka T; Chavrier P; Daillie J
J Virol; 1985 May; 54(2):608-14. PubMed ID: 2985823
[TBL] [Abstract][Full Text] [Related]
22. TPA-inducible Epstein-Barr virus genes in Raji cells and their regulation.
Laux G; Freese UK; Fischer R; Polack A; Kofler E; Bornkamm GW
Virology; 1988 Feb; 162(2):503-7. PubMed ID: 2829433
[TBL] [Abstract][Full Text] [Related]
23. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
Ye J; Gradoville L; Daigle D; Miller G
J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302
[TBL] [Abstract][Full Text] [Related]
24. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
[TBL] [Abstract][Full Text] [Related]
25. Simple repeat sequence in Epstein-Barr virus DNA is transcribed in latent and productive infections.
Heller M; van Santen V; Kieff E
J Virol; 1982 Oct; 44(1):311-20. PubMed ID: 6292493
[TBL] [Abstract][Full Text] [Related]
26. The BamHI J fragment (0.706 to 0.737 map units) of pseudorabies virus is transcriptionally active during viral replication.
Cheung AK
J Virol; 1990 Mar; 64(3):977-83. PubMed ID: 2154623
[TBL] [Abstract][Full Text] [Related]
27. Induction of a deoxyuridine triphosphate nucleotidohydrolase activity in Epstein-Barr virus-infected cells.
Williams MV; Holliday J; Glaser R
Virology; 1985 Apr; 142(2):326-33. PubMed ID: 2997989
[TBL] [Abstract][Full Text] [Related]
28. Homologous upstream sequences near Epstein-Barr virus promoters.
Farrell PJ; Deininger PL; Bankier A; Barrell B
Proc Natl Acad Sci U S A; 1983 Mar; 80(6):1565-9. PubMed ID: 6300857
[TBL] [Abstract][Full Text] [Related]
29. Induction of EBV DNA demethylation and of EBV-specific transcription in Daudi cells treated with TPA and n-butyrate.
Collandre H; Guetard D; Montagnier L
Intervirology; 1984; 22(4):201-10. PubMed ID: 6096292
[TBL] [Abstract][Full Text] [Related]
30. Analysis of Epstein-Barr virus gene expression upon phorbol ester and hydroxyurea treatment by real-time quantitative PCR.
Pan YR; Fang CY; Chang YS; Chang HY
Arch Virol; 2005 Apr; 150(4):755-70. PubMed ID: 15785969
[TBL] [Abstract][Full Text] [Related]
31. Differential effect of phosphonoacetic acid on early antigen synthesis in two Epstein-Barr virus producer cell lines.
Patel P; Menezes J
Virology; 1979 Jan; 92(1):236-9. PubMed ID: 217163
[No Abstract] [Full Text] [Related]
32. Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region.
Parker BD; Bankier A; Satchwell S; Barrell B; Farrell PJ
Virology; 1990 Nov; 179(1):339-46. PubMed ID: 2171209
[TBL] [Abstract][Full Text] [Related]
33. RNA encoded by the IR1-U2 region of Epstein-Barr virus DNA in latently infected, growth-transformed cells.
van Santen V; Cheung A; Hummel M; Kieff E
J Virol; 1983 May; 46(2):424-33. PubMed ID: 6188862
[TBL] [Abstract][Full Text] [Related]
34. p105, an Epstein-Barr virus-induced, phosphonoacetic acid-insensitive glycoprotein target of the anti-Epstein-Barr virus immune response.
Casareale D; Jones W; Sairenji T; Humphreys RE
Infect Immun; 1983 Jan; 39(1):85-90. PubMed ID: 6295961
[TBL] [Abstract][Full Text] [Related]
35. Mapping of putative transforming sequences of EBV DNA.
Kieff E; Raab-Traub N; Given D; King W; Powell AT; Pritchett R; Dambaugh T
IARC Sci Publ (1971); 1978; (24 Pt 1):527-52. PubMed ID: 221358
[TBL] [Abstract][Full Text] [Related]
36. Organization and expression of the major genes from the long inverted repeat of the human cytomegalovirus genome.
Hutchinson NI; Sondermeyer RT; Tocci MJ
Virology; 1986 Nov; 155(1):160-71. PubMed ID: 3022467
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid.
Summers WC; Klein G
J Virol; 1976 Apr; 18(1):151-5. PubMed ID: 176457
[TBL] [Abstract][Full Text] [Related]
38. Phosphonoformate inhibits synthesis of Epstein-Barr virus (EBV) capsid antigen and transformation of human cord blood lymphocytes by EBV.
Margalith M; Manor D; Usieli V; Goldblum N
Virology; 1980 Apr; 102(1):226-30. PubMed ID: 6245504
[No Abstract] [Full Text] [Related]
39. Transcriptional activity across the Epstein-Barr virus genome in Raji cells during latency and after induction of an abortive lytic cycle.
Kirchner EA; Bornkamm GW; Polack A
J Gen Virol; 1991 Oct; 72 ( Pt 10)():2391-8. PubMed ID: 1655954
[TBL] [Abstract][Full Text] [Related]
40. DNA sequence and expression of the B95-8 Epstein-Barr virus genome.
Baer R; Bankier AT; Biggin MD; Deininger PL; Farrell PJ; Gibson TJ; Hatfull G; Hudson GS; Satchwell SC; Séguin C
Nature; 1984 Jul 19-25; 310(5974):207-11. PubMed ID: 6087149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
